SCHEMBL27594966

SCHEMBL27594966

CC(C)CCCCC(=O)OC1CCCC1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 2/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ HTT P42858 1/20 0.41
▸ CYP2C19 P33261 1/20 0.40
▸ METAP1 P53582 1/20 0.39
▸ EPHX1 P07099 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP19A1 P11511 3/20 0.37
▸ KDM4C Q9H3R0 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KDM4A O75164 1/20 0.35
▸ PHF8 Q9UPP1 1/20 0.35
▸ KDM2A Q9Y2K7 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ MMP2 P08253 1/20 0.34
▸ MMP8 P22894 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20924765 0.89 NAAA (0.58) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL16380604 0.88 NAAA (0.68) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL15028306 0.88 NAAA (0.68) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL13667127 0.87 NAAA (0.56) NAAASMN1; SMN2HTTCYP2C19EPHX1
SCHEMBL20924712 0.87 NAAA (0.57) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL16380613 0.87 NAAA (0.69) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL16380552 0.87 NAAA (0.69) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL585907 0.86 NAAA (0.57) NAAASMN1; SMN2HTTCYP2C19EPHX1
SCHEMBL16376178 0.85 NAAA (0.64) NAAASMN1; SMN2HTTCYP2C19METAP1
SCHEMBL16376171 0.85 NAAA (0.64) NAAASMN1; SMN2HTTCYP2C19METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1434803-A Cyclic lactams as inhibitors os A-alpha protein production BRISTOL MYERS SQUIBB CO (US) 2003-08-06 — — CN disclosed
Send feedback